Merck's Keytruda Scores Another Regulatory Nod In Canada

Merck & Co Inc.(MRK) said on Monday that its blockbuster cancer drug Keytruda has received yet another approval in Canada.

The drug has been approved as a treatment for adult patients with high-risk early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment after surgery.

TNBC is a destructive subtype of breast cancer with a tendency to spread quickly. In addition, it also characterized by its high recurrence rate within the first five years after diagnosis. Last year, more than 28,000 Canadian women were estimated to have been diagnosed with breast cancer.

The drug generated annual sales of $17.2 billion in 2021 compared to $14.38 billion in the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ice Cream maker Ben & Jerry's reportedly filed a lawsuit against parent and British consumer giant Unilever to stop the sale of its Israeli business to a local license-holder Avi Zinger. The company alleged that the decision was made without the approval of its independent board. The judge reportedly denied Ben & Jerry's application for a temporary restraining order against Unilever. J&M Foods is recalling certain Lavender Shortbread Cookies sold through department store chain Target Corp. due to undeclared allergens, the U.S. Food and Drug Administration said. These packages were erroneously packed with Chocolate Chip Cookies and do not disclose the presence of a possible allergen, such as soy or eggs. A multi-state listeria outbreak that has killed one and sickened at least 23 others has been linked to Florida -based Big Olaf Creamery brand ice cream, according to the Centers for Disease Control and Prevention or CDC. The outbreak strain has been reported from 10 states, resulting in 22 hospitalizations. One death has been reported from Illinois.
Follow RTT